ADUS (Health Care Services) Stock Valuation & Fair Value Fairly valued
ADUS (Health Care Services) trades at a blended P/E of 17.5, about 19% below its historical normal valuation, with a forward growth estimate of 7.5% and a PEG of 2.34. Analysts' one-year estimates have been hit 73% of the time.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is ADUS overvalued?
At a blended P/E of 17.5 versus its historical normal P/E of 21.7, ADUS trades about 19% below its typical valuation, with a PEG of 2.34 on 7.5% forward growth. tickerseer currently rates it fairly valued.
What is ADUS's fair value and PEG?
ADUS trades at a blended P/E of 17.5 against a historical normal P/E of 21.7, a PEG of 2.34, and a forward growth estimate of 7.5%.
Has tickerseer's rating of ADUS changed?
tickerseer's rating has been fairly valued since 2026-07-31.
Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.